Karen Ling Net Worth & Insider Trades

Karen Ling - Director, Therapeuticsmd, Inc

As of October 3, 2022

What is Karen Ling's Net Worth?

The current estimated net worth of Therapeuticsmd, Inc's Director, Karen Ling, is estimated to be about $5.78M . Karen Ling owns about 130,309 units of Therapeuticsmd, Inc common stock. In the last 2 years at Therapeuticsmd, Inc, Karen Ling has sold an estimated value of $0 worth.

What is Karen Ling's Past Insider Trading?

Karen Ling's largest purchase order was 33,445 units , worth over $25.08K on August 19, 2021. In total, Karen Ling has made about 6 transactions over 2 years of their time at Therapeuticsmd, Inc. Karen Ling usually trades in August, with the busiest year in 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Karen Ling's' Mailing Address?

  • Mailing address is C/o Forest Laboratories, Inc. 909 Third Avenue New York NY 10022 NY

Therapeuticsmd, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert G. Finizio 2020 $600,000 $1,524,751 - $600,000 $21,785 $2,746,536
Robert G. Finizio 2019 $600,000 - $2 $600,000 $22,218 $1,222,220
John C.K. Milligan, IV 2020 $450,000 $1,479,105 - $315,000 $31,285 $2,275,390
John C.K. Milligan, IV 2019 $450,000 - $645,956 $315,000 $29,683 $1,440,639
Edward Borkowski 2020 $430,000 - $3,599,967 $365,500 $81,687 $4,477,154
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/25743/000119312521116458/d152560ddef14a.htm

What are Therapeuticsmd, Inc's Past Insider Trades?

Therapeuticsmd, Inc's most recent insider trade came on October 31, 2022 by Rubric Capital Management Lp and Efraim David Rosen who bought 7,000 units worth $7M . In the last 9 years, insiders at Therapeuticsmd, Inc have sold an estimated value of $50.32M and bought an estimated value of $34.27M worth of shares. Insider trading is most common in August, with the busiest year in 2018. The most active traders at the company are John C.K. Milligan IV, Secretary/CEO subsidiary,  Robert G Finizio, CEO,  and Tommy G Thompson, Director .

TherapeuticsMD, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1